IBDEI1EW ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25035,0)
 ;;=301.89^^144^1557^9
 ;;^UTILITY(U,$J,358.3,25035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25035,1,2,0)
 ;;=2^301.89
 ;;^UTILITY(U,$J,358.3,25035,1,5,0)
 ;;=5^ORGANIC PERSONALITY
 ;;^UTILITY(U,$J,358.3,25035,2)
 ;;=^92448
 ;;^UTILITY(U,$J,358.3,25036,0)
 ;;=715.90^^144^1557^10
 ;;^UTILITY(U,$J,358.3,25036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25036,1,2,0)
 ;;=2^715.90
 ;;^UTILITY(U,$J,358.3,25036,1,5,0)
 ;;=5^OSTEOARTHRITIS
 ;;^UTILITY(U,$J,358.3,25036,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,25037,0)
 ;;=733.00^^144^1557^11
 ;;^UTILITY(U,$J,358.3,25037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25037,1,2,0)
 ;;=2^733.00
 ;;^UTILITY(U,$J,358.3,25037,1,5,0)
 ;;=5^OSTEOPOROSIS NOS
 ;;^UTILITY(U,$J,358.3,25037,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,25038,0)
 ;;=380.10^^144^1557^12
 ;;^UTILITY(U,$J,358.3,25038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25038,1,2,0)
 ;;=2^380.10
 ;;^UTILITY(U,$J,358.3,25038,1,5,0)
 ;;=5^OTITIS EXTERNA
 ;;^UTILITY(U,$J,358.3,25038,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,25039,0)
 ;;=382.9^^144^1557^13
 ;;^UTILITY(U,$J,358.3,25039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25039,1,2,0)
 ;;=2^382.9
 ;;^UTILITY(U,$J,358.3,25039,1,5,0)
 ;;=5^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,25039,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,25040,0)
 ;;=278.02^^144^1557^14
 ;;^UTILITY(U,$J,358.3,25040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25040,1,2,0)
 ;;=2^278.02
 ;;^UTILITY(U,$J,358.3,25040,1,5,0)
 ;;=5^OVERWEIGHT
 ;;^UTILITY(U,$J,358.3,25040,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,25041,0)
 ;;=789.00^^144^1558^1
 ;;^UTILITY(U,$J,358.3,25041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25041,1,2,0)
 ;;=2^789.00
 ;;^UTILITY(U,$J,358.3,25041,1,5,0)
 ;;=5^P.A.T.
 ;;^UTILITY(U,$J,358.3,25041,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,25042,0)
 ;;=427.69^^144^1558^14
 ;;^UTILITY(U,$J,358.3,25042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25042,1,2,0)
 ;;=2^427.69
 ;;^UTILITY(U,$J,358.3,25042,1,5,0)
 ;;=5^PVC
 ;;^UTILITY(U,$J,358.3,25042,2)
 ;;=^87804
 ;;^UTILITY(U,$J,358.3,25043,0)
 ;;=443.9^^144^1558^15
 ;;^UTILITY(U,$J,358.3,25043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25043,1,2,0)
 ;;=2^443.9
 ;;^UTILITY(U,$J,358.3,25043,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,25043,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,25044,0)
 ;;=309.81^^144^1558^13
 ;;^UTILITY(U,$J,358.3,25044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25044,1,2,0)
 ;;=2^309.81
 ;;^UTILITY(U,$J,358.3,25044,1,5,0)
 ;;=5^PTSD
 ;;^UTILITY(U,$J,358.3,25044,2)
 ;;=^114692
 ;;^UTILITY(U,$J,358.3,25045,0)
 ;;=V66.7^^144^1558^2
 ;;^UTILITY(U,$J,358.3,25045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25045,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,25045,1,5,0)
 ;;=5^PALLIATIVE CARE
 ;;^UTILITY(U,$J,358.3,25045,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,25046,0)
 ;;=577.0^^144^1558^3
 ;;^UTILITY(U,$J,358.3,25046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25046,1,2,0)
 ;;=2^577.0
 ;;^UTILITY(U,$J,358.3,25046,1,5,0)
 ;;=5^PANCREATITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,25046,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,25047,0)
 ;;=332.0^^144^1558^4
 ;;^UTILITY(U,$J,358.3,25047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25047,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,25047,1,5,0)
 ;;=5^PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,25047,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,25048,0)
 ;;=420.91^^144^1558^5
 ;;^UTILITY(U,$J,358.3,25048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25048,1,2,0)
 ;;=2^420.91
 ;;^UTILITY(U,$J,358.3,25048,1,5,0)
 ;;=5^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,25048,2)
 ;;=^269695
 ;;^UTILITY(U,$J,358.3,25049,0)
 ;;=462.^^144^1558^6
 ;;
 ;;$END ROU IBDEI1EW
